FectoVIR®-AAV Transfection Reagent for rAAV Production in Suspension, Polyplus-transfection

Supplier: Polyplus-transfection
FectoVIR®-AAV
101000004 101000044 101000022 101000044 101000022 101000004
CA76469-812EA 18035.58 CAD
CA76469-812 76469-812 CA76469-810 76469-810 CA76469-808 76469-808
FectoVIR®-AAV Transfection Reagent for rAAV Production in Suspension, Polyplus-transfection
Transfection Reagents
Next generation of transfection reagent for rAAV production in suspension.

  • High performance: Superior yield for AAV production
  • Scalability: Developed for small to large scale manufacturing
  • Flexibility: Compatible with commercial culture media
  • Trustworthy: #1 transfection supplier of gene and cell therapy
  • GMP compliance: GMP grade coming soon

FectoVIR®-AAV is a novel class of animal-free transfection reagent specifically developed for research development up to industrial scale production of recombinant AAV (rAAV) viral vectors in suspension HEK-293 cell types.

FectoVIR®-AAV transfection reagent guarantees higher rAAV viral titers, improved flexibility and scalability for industrial scale manufacturing.

Certifications: Since 2002, Polyplus-transfection® is ISO 9001 certified and since then this certification has been successfully renewed every three years.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR